In fewer than five years, Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR genome-editing technology, has taken the scientific community by storm, not only revolutionizing the pace of biological breakthroughs but also promising medicines that cure diseases now considered incurable. Please enjoy a primer to assist in understanding DNA, the human genome, and the rise of CRISPR. For an in-depth review of CRISPR and the investment opportunities please download our research white papers on “The CRISPR Market Opportunity and Key Players” and “The CRISPR IP Landscape”.
The structure of DNA, the double-stranded helix
The human genome is composed of 3.2 billion base pairs of DNA, or lines of code, a single error in which could cause disease.1,2 Biological tools are evolving that should be able to correct these errors, or mutations, easily and cost-effectively, making cures for diseases possible for the first time in history.
The ability to control genes holds the promise of a cure for any disease. The 23,000 genes in each human genome contain instructions that guide the production of proteins, which are the building blocks that govern the functioning of the human body. Proteins fight infections, carry oxygen, clot blood after injury, and control muscle movements. They regulate brain signals, trigger smells, and form finger and toe nails. Each of these functions depends upon precise amounts of specific proteins.
The Rise of CRISPR
Gene-editing debuted during the biotechnology revolution. As shown below, the first targeted edit was in a yeast cell during the 1980s. Major therapeutic breakthroughs associated with gene-editing have taken place only in the past decade. Today, genome-editing is a rapidly developing field for 21stcentury medicine.
CRISPR is a simple, powerful and programmable genome-editing tool. An acronym for Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR was discovered in a study of viral invaders and bacterial immune defense systems.3
According to ARK’s research, unlike previous gene splicing tools, not only does CRISPR have a wide range of applications, but it also is accessible and fast. While associated primarily with gene-editing today, CRISPR ultimately will be able to control gene processes and protein expression. As a result, CRISPR is evolving into a novel technology platform in the bioengineering space, accelerating innovation in a number of areas, including:
- Basic Research
- Drug Discovery/ Animal Models
- Drug Development/ Therapeutics
- Data Storage
- Material Sciences
ARK’s research whitepaper:
The information provided is for informational purposes only. It does not constitute any form of advice or recommendation to buy or sell any securities mentioned. It is intended only to provide observations and views of the author(s) at the time of writing, both of which are subject to change at any time without prior notice. Certain of the statements contained herein are statements of future expectations and other forward-looking statements that are based on ARK's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Past performance is no guarantee of future results. Equities may decline in value due to both real and perceived general market, economic, and industry conditions. For a list of all purchases and sales made by ARK for client accounts during the past year that could be considered by the SEC as recommendations, click here. It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the securities in this list. For full disclosures, click here.